Bladder-specific therapies (e.g., Pentosan Polysulfate Sodium - Elmiron)

Type: drug

Status: FDA Approved

Developer: Janssen Pharmaceuticals

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026